Objectives Pleural metastasis has extremely poor prognosis. Resection of pleural implants
with infusion of intrathoracic hyperthermic chemotherapy may offer a survival advantage in …

(1) Background: Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor
arising from the pleural surface. For relapsed MPM, there is no accepted standard of-are for …

Pleural mesothelioma is a fatal disease with limited treatment options. Recently, pleural
mesothelioma management has improved with the development of immune checkpoint …

Objective To compare the efficacy and safety of hyperthermic intrathoracic/intraperitoneal
chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy in the …

Hyperthermic intrathoracic chemotherapy (HITHOC) adjunct to surgery for Malignant Pleural
Mesothelioma (MPM) has no definite role. The primary objective of this pilot-trial was to …

Malignant pleural mesothelioma (MPM) represents a significant clinical challenge due to
limited therapeutic options and poor prognosis. Beyond mere survivorship, setting up an …

Malignant pleural mesothelioma (MPM) is an aggressive malignancy with few long-term
survivors. Despite the dismal prognosis, hyperthermic intrathoracic chemoperfusion (HITOC) …

Thymomas are rare tumors of the anterior mediastinum with peculiar clinical and
pathological features. They have been deeply analyzed by pioneer authors, who strictly …

Simple Summary The role of surgery in the combined treatment with hyperthermic
intrathoracic chemotherapy of thymoma recurrences and pleural mesothelioma has …

Aims Pleural mesothelioma (PM) is a highly aggressive thoracic tumour with poor prognosis.
Although reduced tissue drug accumulation is one of the key features of platinum (Pt) …